Increasing screen time during COVID-19 could be harmful to kids’ eyesight

by: Shu-Fang Shih, University of Michigan (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Shu-Fang Shih, University of Michigan and Olivia Killeen, University of Michigan (THE CONVERSATION) The...

Parkinson’s disease symptoms: The sign in your vision you need to look out for

PARKINSON's can cause crazy visions. Can sufferers really believe what they are seeing? What could you expect to see from someone who has the brain disease? By CHANEL GEORGINA Parkinson's gradually damages the brain. Over time, symptoms will begin to appear. When the...

Early detection with ForeseeHome

by: Jeffry Gerson, OD, FAAO- Medical Director of the Optometric Board for the Macular Degeneration Association (MDA) For those with macular degeneration, a question I often hear is “What can I do?” Hopefully, if you are in this “boat” you have heard about the...

Could Sanofi and Regeneron’s Dupixent also treat age-related macular degeneration?

New Research by Angus Liu  Sanofi and Regeneron’s Dupixent has already proven its value in treating atopic dermatitis and asthma. But could it also prove useful in age-related macular degeneration (AMD), a common cause of blindness in people over age 65? A...

Regeneron says antibody for COVID-19 could be ready this year

Two antibody cocktails for COVID-19 could be available as early as this autumn Regeneron says antibody for COVID-19 could be ready this year Two antibody cocktails for COVID-19 could be available as early as this autumn Regeneron has kicked off an accelerated...

Vision Health and Covid-19 Update from the Canadian Ophthalmological Society

OTTAWA, May 1, 2020 /CNW/ - May is vision health month and the Canadian Ophthalmological Society would like to remind you of some important information about your eyes and COVID-19. Avoid touching your eyes – We can't stress this enough. Washing your hands,...

First patient dosed in cohort 4 of Adverum OPTIC trial

New trial. The first patient in cohort 4 has been dosed in the ongoing phase 1 OPTIC trial of ADVM-022, according to a press release from Adverum Biotechnologies. Nine patients with wet age-related macular degeneration will receive a single intravitreal injection of...

BLOG: What we need to know about hydroxychloroquine retinal toxicity during COVID-19

By: Doug Rett, OD, F.A.A.O n his blog, Doug Rett, OD, FAAO, digs deeper into questions every eye doctor has had at one point in his or her career. He sees patients and works with students and residents at the optometry clinic for the VA Boston Healthcare System and...

Researchers find potential new target for eye disease therapy

by: Selina McKee Research led by scientists at Trinity College Dublin has pinpointed a potential new therapeutic target for treating retinal degeneration. The work discovered that a protein (SARM1) involved in neuronal cell injury could also play a role in the...

While at home, remember increased screen time can have negative side effects

by Kirstie Burgess, Staff WriterApril 26, 2020 Due to the coronavirus, many people have had to change their homes into spaces for learning and working. One of the downsides of this shift is the negative impacts of the increased exposure to blue light created by...
On